Alto Neuroscience, Inc. (ANRO) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-05-29

Alto Neuroscience, Inc. (ANRO) has filed 7 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-29. 5 Form 8-K material event filings were reported by ANRO in the last 90 days. InsiderAlpha tracks every ANRO SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Alto Neuroscience, Inc. (ANRO)

SEC CIK	0001999480

90-Day SEC Filing Activity

Form 4 filings (90d)	7
Form 8-K filings (90d)	5
Latest Form 4 filing	2026-05-29

Recent ANRO Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-05-14	Etkin Amit	PRESIDENT AND CEO	G — Bona-fide gift	400.0K	$0.00	—	SEC
2026-03-01	Etkin Amit	PRESIDENT AND CEO	F — Tax withholding / forfeiture	6.2K	$19.69	$123K	SEC
2026-03-01	Smith Nicholas Conrad	CHIEF FINANCIAL OFFICER & CBO	F — Tax withholding / forfeiture	2.8K	$19.69	$55K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Alto Neuroscience, Inc. (ANRO). Updated in real time as new filings are submitted to the SEC.

Most-Active ANRO Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
Sanchez Ramiro	1	—
Etkin Amit	1	—
Miller Andrew Craig	1	—
Cox Christopher Nixon	1	—
Manji Husseini	1	—

Recent ANRO Form 8-K Material Events

2026-07-14 — Item 1.01, 9.01 [SEC]
2026-07-13 — Item 2.02, 8.01 [SEC]
2026-05-28 — Item 5.02 [SEC]
2026-05-13 — Item 5.02, 5.07, 9.01 [SEC]
2026-05-13 — Item 2.02, 9.01 [SEC]

Recent Insider Filings

2026-05-29 — Miller Andrew Craig (Director)
2026-05-15 — Etkin Amit (PRESIDENT AND CEO)
2026-05-14 — Sanchez Ramiro (Director)
2026-05-14 — Cox Christopher Nixon (Director)
2026-05-14 — Manji Husseini (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ANRO insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

ANRO Insider Trading — FAQ

What is the latest insider trade for ANRO?: Alto Neuroscience, Inc. (ANRO) had 7 insider filings in the last 90 days, with the most recent on 2026-05-29. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying ANRO stock?: 0 insider purchases of ANRO were filed in the last 90 days.
How many insiders are selling ANRO stock?: 0 insider sales of ANRO were filed in the last 90 days.
Where can I see ANRO SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every ANRO SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live ANRO dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.